The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights-Reference-Cited by-同舟云学术

The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights

Published:2016-12-28 Issue:3 Volume:26 Page:310-319
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Curtis Jeffrey R.¹,Chen Lang¹,Greenberg Jeffrey D.²,Harrold Leslie³,Kilgore Meredith L.¹,Kremer Joel M.⁴,Solomon Daniel H.⁵,Yun Huifeng¹

Affiliation:

1. University of Alabama at Birmingham; Birmingham AL USA

2. NYU School of Medicine; New York NY

3. University of Massachusetts; Worcester MA USA

4. Albany Medical College, The Center for Rheumatology

5. Brigham and Women's Hospital; Boston MA USA

Funder

National Institutes of Health

Agency for Healthcare Research and Quality

CORRONA, LLC.

AbbVie, Amgen, Astra Zeneca, BMS, Crescendo, Genentech, Horizon Pharma USA, Janssen, Eli Lilly, Novartis, Pfizer, and UCB

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.4126/fullpdf

Reference22 articles.

1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update;Smolen;Ann Rheum Dis,2014

2. Treating rheumatoid arthritis to target: recommendations of an international task force;Smolen;Ann Rheum Dis,2011

3. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis;Singh;Arthritis Care Res (Hoboken),2012

4. Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: Experience from a large U.S. cohort;Zhang;Arthritis Care Res (Hoboken),2011

5. Patient perspectives on achieving treat-to-target goals: A critical examination of patient-reported outcomes;Curtis;Arthritis Care Res (Hoboken),2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐World Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating First‐Line Tumor Necrosis Factor Inhibitor Therapy in the United States;ACR Open Rheumatology;2024-01-14

2. Rheumatoid Arthritis Disease Activity and Hospitalized Infection in a Large US Registry;Arthritis Care & Research;2023-03-02

3. Geographic Variation in Disease Burden and Mismatch in Care of Patients With Rheumatoid Arthritis in the United States;ACR Open Rheumatology;2023-02-21

4. Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry;Rheumatology and Therapy;2022-11-04

5. The Economic Benefit of Remission for Patients with Rheumatoid Arthritis;Rheumatology and Therapy;2022-07-14